Does antibacterial treatment for urinary tract infection contribute to the risk of breast cancer?

British Journal of Cancer

Volumn 82, Issue 5, 2000, Pages 1107-1110

  Knekt, P ^a   Adlercreutz, H ^b,c   Rissanen, H ^a   Aromaa, A ^a   Teppo, L ^d   Heliovaara M ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b FOLKHÄLSAN RESEARCH CENTER   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d FINNISH CANCER REGISTRY   (Finland)

Author keywords

Antibiotics; Breast; Chemotherapy; Longitudinal studies; Neoplasms; Urinary tract infections

Indexed keywords

ANTIINFECTIVE AGENT; CEPHALOSPORIN; CHLORAMPHENICOL; ERYTHROMYCIN; LIGNAN; NALIDIXIC ACID; NITROFURANTOIN; PENICILLIN G; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER RISK; DRUG USE; FEMALE; FINLAND; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PREMENOPAUSE; PRIORITY JOURNAL; URINARY TRACT INFECTION;

EID: 0034011845     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.1047     Document Type: Article

References (14)

1. Adlercreutz H (1998) Human health and phytoestrogens. In: Reproductive and Development Toxicology, Korach KD (ed), pp. 299-371. Marcel Dekker: New York
2. Adlercreutz H and Mazur W (1997) Phyto-oestrogens and Western diseases. Ann Med 29: 95-120
3. Adlercreutz H, Fotsis T, Bannwart C, Wähälä K, Mäkelä T, Brunow G and Gorbach SL (1986) Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets. J Steroid Biochem 25: 791-797
4. Adlercreutz H, Fotsis T, Heikkinen R, Dwyer JT, Woods M, Goldin BR and Gorbach SL (1982) Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer. Lancet ii: 1295-1299
5. Barnett BJ and Stephens DS (1997) Urinary tract infection: an interview. Am J Med Sci 314: 245-249
6. Borriello SP, Setchell KD, Axelson M and Lawson AM (1985) Production and metabolism of lignans by the human faecal flora. J Appl Bacteriol 58: 37-43
7. Cox DR (1972) Regression models and life-tables (with discussion). J R Stat Soc B 34: 187-220
8. Harris JR, Lippman ME, Veronesi U and Willett W (1992) Breast cancer. N Engl J Med 327: 319-328
9. Hulten K, Winkwist A, Adlercreutz H, Lenner P, Johansson R and Hallmans G (1998) A prospective study on lignans and breast cancer. The Cost 916 Workshop on Phyto-oestrogens: exposure, bioavailability, health benefits and safety concerns. Doorwerth, The Netherlands, 17-18 April
10. Ingram D, Sanders K, Kolybaba M and Lopez D (1998) Case-control study of phyto-oestrogens and breast cancer. Lancet 350: 990-994
11. Knekt P, Marniemi J, Teppo L, Heliövaara M and Aromaa A (1998) Is low selenium status a risk factor for lung cancer? Am J Epidemiol 148: 975-982
12. Setchell KD, Lawson AM, Borriello SP, Harkness R, Gordin H, Morgan DM, Kirk DN, Adlercreutz H, Anderson LC and Axelson M (1981) Lignan formation in man-microbial involvement and possible roles in relation to cancer. Lancet ii: 4-7
13. Teppo L, Pukkala E and Lehtonen M (1994) Data quality and quality control of a population-based cancer registry. Experiences in Finland. Acta Oncol 33: 365-369
14. World Health Organization (1955) International Classification of Diseases. Manual of international statistical classification of diseases, injuries, and causes of death, 7th Revision. World Health Organization: Geneva